Revolution Medicines (RVMD) Non-Current Deffered Revenue (2019 - 2022)
Revolution Medicines (RVMD) recorded Non-Current Deffered Revenue of $5.42 million in Q3 2022, down 44.0% from $9.68 million a year earlier but up 41.2% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Non-Current Deffered Revenue (2019 - 2022) Analysis & Trends
At the end of FY2021, Revolution Medicines reported Non-Current Deffered Revenue of $6.57 million, down 22.5% from FY2020.
- Across earlier years, Non-Current Deffered Revenue came in at $8.48 million in FY2020 (-42.4%) and $14.73 million in FY2019.
- Quarterly Non-Current Deffered Revenue has ranged from $3.84 million in Q2 2022 to $14.73 million in Q4 2019 over the past five years.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for eight consecutive quarters, with an average decline of 32.3% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 1.0% (Q3 2021) to 49.7% (Q2 2022).
- Per Business Quant, the preceding three quarters came in at $3.84 million (Q2 2022), $5.66 million (Q1 2022) and $6.57 million (Q4 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 5.42 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 5.66 Mn |
| Dec 31, 2021 | 6.57 Mn |
| Sep 30, 2021 | 9.68 Mn |
| Jun 30, 2021 | 7.62 Mn |
| Mar 31, 2021 | 8.14 Mn |
| Dec 31, 2020 | 8.48 Mn |
| Sep 30, 2020 | 9.77 Mn |
| Jun 30, 2020 | 11.61 Mn |
| Mar 31, 2020 | 12.42 Mn |
| Dec 31, 2019 | 14.73 Mn |
API Access
Revolution Medicines Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();